Aldel Financial II Inc. (ALDFU) Prices $200M IPO
by Nicholas Alan Clayton on 2024-10-21 at 5:22pm

Aldel Financial II Inc. announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ALDFU”, Tuesday, October 22, 2024.

The new SPAC plans to combine with an established business of scale with prospects for positive cash flow and the infrastructure to handle being a public company.

The sponsor team for Aldel II is to be led by Chief Executive Office Robert I. Kauffman alongside Chief Financial Officer and Secretary Hassan R. Baqar. Its Board is to be made up of nominees Stuart Kovensky, Jonathan Marshall, Meltem Demirors, and Peter Early.

Total SPAC deal count for 2024 year-to-date is now 38. This offering is expected to close on Wednesday, October 23, 2024.


BTIG, LLC is acting as sole book-running manager for the offering. Loeb & Loeb LLP is serving as Issuer’s Counsel with White & Case LLP serving as Underwriter’s Counsel. Fruci Associates II PLLC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.

Recent Posts
by Kristi Marvin on 2024-10-26 at 10:00am

Terms Tracker for the Week Ending October 25, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Finally, a little more SPAC action this week with no less than four IPOs priced.  That brings October’s tally to seven IPOs with one more...

by Nicholas Alan Clayton on 2024-10-25 at 8:15am

At the SPAC of Dawn The rebound of the growth companies that made up the SPAC class of 2021 has been one of the bigger stories of second half of 2024, but not all of the de-SPACs are feeling the love equally. Instead, in many new sectors that hit the public markets together as a...

by Nicholas Alan Clayton on 2024-10-24 at 11:54am

DT Cloud (NASDAQ:DYCQ) has entered into a definitive agreement to combine with Maius Pharmaceutical at an equity value of $250 million. Shanghai-based Maius is a drug developer and researcher focused on small-molecule chemical treatments for different forms of cancer. The combined company is expected to trade on the Nasdaq once the deal is completed in...

by Nicholas Alan Clayton on 2024-10-24 at 10:18am

Charlton Aria Acquisition Corporation announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CHARU”, Thursday, October 24, 2024. The new SPAC plans to focus on industries that complement the management team’s and board of director’s background and network. The sponsor team for...

by Nicholas Alan Clayton on 2024-10-24 at 8:30am

At the SPAC of Dawn As the market goes through a cooling period this week, new readouts for jobless claims and new home sales are set to hit later today. Jobless claims are of course something of a proxy indicator for SPACs as to when the Fed might continue to its rate-cutting process, while home...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved